Developer docs
API playgroundTry for free, no card

Search company profiles

handl Group

Full company profile

uuid000ki7v

Namestring
handl Group
Company typeenum
Private
Founded yearstring
-
Descriptiontext

handl Group is a private UK holding company headquartered in Chorley that operates a health and wellbeing division delivering specialist neurorehabilitation services. Its core service line centers on spasticity management using botulinum toxins, delivered through acquired brands Paediatric Specialist Physiotherapy (PSP) and Osiris Health, which serve paediatric and adult patient populations respectively. The firm's firmographic short-description positions it more broadly as an Executive Office service provider spanning legal, insurance, and healthcare sectors, indicating a portfolio that extends beyond the healthcare detail surfaced in the available sources.

The company pursues growth through acquisition-led expansion rather than organic hiring, having completed three acquisitions since 2021: Reach Personal Injury in January 2021 and the simultaneous acquisitions of PSP and Osiris Health in June 2024. Acquired brands are retained within the health and wellbeing division and integrated into a multidisciplinary neurorehabilitation offering targeting complex care. Revenue is generated through professional services, distributed via the UK healthcare referral network including NHS trusts, private hospitals, and referring clinicians. No pricing, contract value, or revenue figures are publicly disclosed.

Operationally, handl Group functions as a lean roll-up acquirer with very small reported corporate headcount (1-10 employees) but meaningful clinical capacity through its operating subsidiaries. The firm develops no software or technology platform, and no AI or API capabilities are evidenced; its differentiation rests on clinical domain specialization in botulinum toxin-based spasticity management. Operating geographies are concentrated in North West England, and no funding, ownership, or leadership information is disclosed in the available sources.

Short descriptiontext

handl Group is a private UK holding company operating a health and wellbeing division that delivers specialist neurorehabilitation services, particularly botulinum toxin-based spasticity management, through acquired brands serving paediatric and adult patients in North West England.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersChorley, United Kingdom
HQ citystring
Chorley
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
neurorehabilitation services, spasticity management, paediatric physiotherapy, complex care services, specialist rehabilitation
NAICS code1 code
  • Offices of Other Health Practitioners6213
SIC code3 codes
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-Health Services8000
  • Services-Misc Health & Allied Services, Nec8090
Product category
Neurorehabilitation Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Healthcare and Rehabilitation Services
TypeProfessional Services
Description

Handl Group generates revenue through its health and wellbeing division by providing specialist neurorehabilitation services, including physiotherapy and spasticity management treatments. The company serves patients requiring complex care and rehabilitation therapy.

handlgroup.co.uk
Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

handl Group delivers specialist neurorehabilitation and complex care services through its Health and Wellbeing division, with a focus on spasticity management using botulinum toxin injections for both children and adults. The group's service portfolio is delivered via acquired specialist brands (Paediatric Specialist Physiotherapy/PSP and Osiris Health) operating in the North West of England, providing integrated, multidisciplinary rehabilitation therapy to patients referred through the UK healthcare system.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Expansion of clinical services and patient access through acquisition integration
Product overview1 text field

handl Group operates as a healthcare company with a health and wellbeing division providing specialist rehabilitation services. The portfolio consists of acquired neuro rehabilitation brands (Paediatric Specialist Physiotherapy/PSP and Osiris Health) that specialize in spasticity management using botulinum toxins. These acquired companies have been integrated into the health and wellbeing division to create an enhanced multidisciplinary neurorehabilitation offering for both children and adults. The company does not appear to offer a unified software platform but rather operates as a healthcare service provider with multiple specialist rehabilitation brands.

Product and service3 records
1Paediatric Specialist Physiotherapy (PSP)
CategoryPaediatric neurorehabilitation
Description

North West England-based specialist paediatric physiotherapy and neurorehabilitation service for children with neurological conditions, with particular expertise in spasticity management using botulinum toxin injections; integrated into handl Group's Health and Wellbeing division.

2Osiris Health
CategoryAdult neurorehabilitation
Description

North West England-based specialist adult neurorehabilitation service offering spasticity management using botulinum toxins and broader complex care rehabilitation for adult patients; integrated into handl Group's Health and Wellbeing division.

3Health and Wellbeing Division Services
CategoryIntegrated neurorehabilitation and complex care
Description

handl Group's umbrella specialist healthcare service covering interdisciplinary neurorehabilitation, complex care, and spasticity management for children and adults in the UK; encompasses the PSP and Osiris Health brands alongside other specialist rehabilitation services.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeOthersAnnounced on2024-06-10
Description

Handl Group acquired PSP, a North West-based neurorehabilitation company specializing in spasticity management using botulinum toxins for children. The acquisition integrates PSP into Handl's health and wellbeing division to enhance complex care services.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Large UK not-for-profit health and wellbeing operator offering physiotherapy, neuro-rehab, and outpatient services nationwide; competes with handl Group for NHS contracts and private referrals, but at significantly broader scale and scope.

TypeBroad incumbent
Description

UK private hospital group providing outpatient and inpatient services including physiotherapy and rehabilitation; overlaps with handl Group in private-pay rehabilitation demand but operates many sites and many specialties beyond neuro-rehab.

TypeEmerging player
Description

UK independent physiotherapy provider offering specialist neuro and MSK services including some spasticity management; comparable as a smaller specialist competitor in the same NHS/private referral ecosystem as handl Group.

TypeBroad incumbent
Description

Operates major UK private hospitals (e.g., The Wellington, Portland) with specialist neuro-rehabilitation services; competes for high-acuity private neuro-rehab referrals that could otherwise route to handl Group's specialists.

TypeEmerging player
Description

Large UK physiotherapy network delivering MSK and some neurological rehabilitation, often via NHS contracts; comparable to handl Group in clinical delivery model and NHS commissioning, though focused on MSK rather than paediatric neuro-rehab.

TypeBroad incumbent
Description

Kent-based private hospital group expanding outpatient and rehabilitation services in the South East; an indirect competitor for NHS-insourced and private rehab work, but with a broader elective-care portfolio.

TypeEmerging player
Description

UK community-based provider of MSK and pain rehabilitation services with significant NHS contract exposure; relevant peer given shared NHS commissioning routes and physiotherapy-led service model.

TypeDirect peer
Description

UK specialist provider of neurological rehabilitation including spasticity management and botulinum toxin services across the South of England; the closest direct comparator to handl Group's paediatric and adult neurorehabilitation offering in the North West.

TypeBroad incumbent
Description

UK private hospital operator with rehabilitation and outpatient services; relevant comparator on NHS-insourced rehabilitation contracts and private physiotherapy, though its portfolio spans many surgical and medical specialties beyond neuro-rehab.

TypeBroad incumbent
Description

UK private hospital and outpatient network providing physiotherapy and rehabilitation services across multiple regions; comparable on NHS Partnership and private-pay channels to handl Group.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

handl Group

Neurorehabilitation Serviceshandlgroup.co.uk

handl Group is a private UK holding company operating a health and wellbeing division that delivers specialist neurorehabilitation services, particularly botulinum toxin-based spasticity management, through acquired brands serving paediatric and adult patients in North West England.

What handl Group does

handl Group is a private UK holding company headquartered in Chorley that operates a health and wellbeing division delivering specialist neurorehabilitation services. Its core service line centers on spasticity management using botulinum toxins, delivered through acquired brands Paediatric Specialist Physiotherapy (PSP) and Osiris Health, which serve paediatric and adult patient populations respectively. The firm's firmographic short-description positions it more broadly as an Executive Office service provider spanning legal, insurance, and healthcare sectors, indicating a portfolio that extends beyond the healthcare detail surfaced in the available sources.

The company pursues growth through acquisition-led expansion rather than organic hiring, having completed three acquisitions since 2021: Reach Personal Injury in January 2021 and the simultaneous acquisitions of PSP and Osiris Health in June 2024. Acquired brands are retained within the health and wellbeing division and integrated into a multidisciplinary neurorehabilitation offering targeting complex care. Revenue is generated through professional services, distributed via the UK healthcare referral network including NHS trusts, private hospitals, and referring clinicians. No pricing, contract value, or revenue figures are publicly disclosed.

Operationally, handl Group functions as a lean roll-up acquirer with very small reported corporate headcount (1-10 employees) but meaningful clinical capacity through its operating subsidiaries. The firm develops no software or technology platform, and no AI or API capabilities are evidenced; its differentiation rests on clinical domain specialization in botulinum toxin-based spasticity management. Operating geographies are concentrated in North West England, and no funding, ownership, or leadership information is disclosed in the available sources.

handl Group firmographics

Firmographics
Name
handl Group
Website
https://handlgroup.co.uk
Company type
Private
Operating status
Operating
Headcount range
1–10 employees
Short description
handl Group is a private UK holding company operating a health and wellbeing division that delivers specialist neurorehabilitation services, particularly botulinum toxin-based spasticity management, through acquired brands serving paediatric and adult patients in North West England.
Ownership category
akta.pro rank

Where handl Group is headquartered

Location

Headquarters

HQ city
Chorley
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

handl Group business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Healthcare and Rehabilitation Services: Handl Group generates revenue through its health and wellbeing division by providing specialist neurorehabilitation services, including physiotherapy and spasticity management treatments. The company serves patients requiring complex care and rehabilitation therapy.

Go-to-market motion1 record

Distribution channels1 record

handl Group product offering

Product offering

Core offering

handl Group delivers specialist neurorehabilitation and complex care services through its Health and Wellbeing division, with a focus on spasticity management using botulinum toxin injections for both children and adults. The group's service portfolio is delivered via acquired specialist brands (Paediatric Specialist Physiotherapy/PSP and Osiris Health) operating in the North West of England, providing integrated, multidisciplinary rehabilitation therapy to patients referred through the UK healthcare system.

Product overview

handl Group operates as a healthcare company with a health and wellbeing division providing specialist rehabilitation services. The portfolio consists of acquired neuro rehabilitation brands (Paediatric Specialist Physiotherapy/PSP and Osiris Health) that specialize in spasticity management using botulinum toxins. These acquired companies have been integrated into the health and wellbeing division to create an enhanced multidisciplinary neurorehabilitation offering for both children and adults. The company does not appear to offer a unified software platform but rather operates as a healthcare service provider with multiple specialist rehabilitation brands.

Differentiator

Problem solved

Functional benefit

Products and services

  • Paediatric Specialist Physiotherapy (PSP) North West England-based specialist paediatric physiotherapy and neurorehabilitation service for children with neurological conditions, with particular expertise in spasticity management using botulinum toxin injections; integrated into handl Group's Health and Wellbeing division.
  • Osiris Health North West England-based specialist adult neurorehabilitation service offering spasticity management using botulinum toxins and broader complex care rehabilitation for adult patients; integrated into handl Group's Health and Wellbeing division.
  • Health and Wellbeing Division Services handl Group's umbrella specialist healthcare service covering interdisciplinary neurorehabilitation, complex care, and spasticity management for children and adults in the UK; encompasses the PSP and Osiris Health brands alongside other specialist rehabilitation services.

Quantifiable outcome

  • Expansion of clinical services and patient access through acquisition integration

Companies that use handl Group

Customer profile

Named customers2 records

Segments2 records

Ideal customer profiles2 records

handl Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

handl Group partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Paediatric Specialist Physiotherapy (PSP)coreOthers · 10 June 2024Handl Group acquired PSP, a North West-based neurorehabilitation company specializing in spasticity management using botulinum toxins for children. The acquisition integrates PSP into Handl's health and wellbeing division to enhance complex care services.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

handl Group competitors and assessment

Company assessment

Broad incumbents

  • Nuffield Health: Large UK not-for-profit health and wellbeing operator offering physiotherapy, neuro-rehab, and outpatient services nationwide; competes with handl Group for NHS contracts and private referrals, but at significantly broader scale and scope.
  • Spire Healthcare: UK private hospital group providing outpatient and inpatient services including physiotherapy and rehabilitation; overlaps with handl Group in private-pay rehabilitation demand but operates many sites and many specialties beyond neuro-rehab.
  • HCA Healthcare UK: Operates major UK private hospitals (e.g., The Wellington, Portland) with specialist neuro-rehabilitation services; competes for high-acuity private neuro-rehab referrals that could otherwise route to handl Group's specialists.
  • KIMS Hospital: Kent-based private hospital group expanding outpatient and rehabilitation services in the South East; an indirect competitor for NHS-insourced and private rehab work, but with a broader elective-care portfolio.
  • Circle Health Group: UK private hospital operator with rehabilitation and outpatient services; relevant comparator on NHS-insourced rehabilitation contracts and private physiotherapy, though its portfolio spans many surgical and medical specialties beyond neuro-rehab.
  • Ramsay Health Care UK: UK private hospital and outpatient network providing physiotherapy and rehabilitation services across multiple regions; comparable on NHS Partnership and private-pay channels to handl Group.

Emerging players

  • Pure Physiotherapy: UK independent physiotherapy provider offering specialist neuro and MSK services including some spasticity management; comparable as a smaller specialist competitor in the same NHS/private referral ecosystem as handl Group.
  • Ascenti: Large UK physiotherapy network delivering MSK and some neurological rehabilitation, often via NHS contracts; comparable to handl Group in clinical delivery model and NHS commissioning, though focused on MSK rather than paediatric neuro-rehab.
  • Connect Health: UK community-based provider of MSK and pain rehabilitation services with significant NHS contract exposure; relevant peer given shared NHS commissioning routes and physiotherapy-led service model.

Direct peers

  • Hobbs Rehabilitation: UK specialist provider of neurological rehabilitation including spasticity management and botulinum toxin services across the South of England; the closest direct comparator to handl Group's paediatric and adult neurorehabilitation offering in the North West.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

handl Group social profiles

Digital presence

handl Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

handl Group leadership team

Management profile

Number of profiles

handl Group subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

handl Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

handl Group M&A and investment

M&A and investment

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about handl Group

What does handl Group do?

handl Group delivers specialist neurorehabilitation and complex care services through its Health and Wellbeing division, with a focus on spasticity management using botulinum toxin injections for both children and adults. The group's service portfolio is delivered via acquired specialist brands (Paediatric Specialist Physiotherapy/PSP and Osiris Health) operating in the North West of England, providing integrated, multidisciplinary rehabilitation therapy to patients referred through the UK healthcare system.

Is handl Group a public or private company?

handl Group is a private company. It is classified as unknown and is currently operating.

When was handl Group founded?

handl Group was founded in -1. It employs 1 to 10 people.

Where is handl Group based?

handl Group is headquartered in Chorley, United Kingdom, in the Europe region.

How does handl Group make money?

One revenue line is on record: healthcare and Rehabilitation Services.

Who are handl Group's main competitors?

Broad incumbents on record are Nuffield Health, Spire Healthcare, HCA Healthcare UK, KIMS Hospital, Circle Health Group and Ramsay Health Care UK. Emerging players are Pure Physiotherapy, Ascenti and Connect Health. Hobbs Rehabilitation is listed as a direct peer.

Does handl Group have an API?

No public API is recorded for handl Group.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Insurance TimesHandl Group announces double acquisitionHandl Group announced the acquisition of two companies, Paediatric Specialist Physiotherapy (PSP) and Osiris Health, to strengthen its position in the neuro rehabilitation market. These firms will join Handl’s health and wellbeing division as part of a strategy to scale services and enhance clinical capabilities. The group plans further acquisitions in this sector to expand its portfolio.LaingBuisson NewsHandl Group acquisitions strengthen neurorehabilitation capabilitiesHandl Group has acquired Paediatric Specialist Physiotherapy (PSP) and Osiris Health to expand its health and wellbeing division. The company stated that these acquisitions are intended to strengthen its existing neurorehabilitation capabilities, though specific financial terms were not disclosed.Health & ProtectionHandl Group acquires Paediatric Specialist Physiotherapy and Osiris HealthHandl Group has acquired Paediatric Specialist Physiotherapy and Osiris Health to expand its health and wellbeing division. The acquisition aims to scale these brands alongside existing entities like Reach and Mind Right to meet growing demand for specialist rehabilitation services. Handl Group plans to continue exploring further acquisitions in the sector to enhance its service offerings.HandlgroupWe’re proud to welcome PSP and Osiris Health to handl Grouphandl Group has acquired PSP and Osiris Health, two North West-based neuro rehabilitation specialists, to expand its health and wellbeing division. The acquisition integrates these entities into handl Group's existing portfolio to enhance complex care services and spasticity management for both children and adults. PSP's Peter Sanderson will remain as Clinical Services Director to support the group's strategic alignment and clinical expertise.Handlgrouphandl Group purchases market leading provider of case management, expert witness and rehabilitation servicesFL360, trading as handl Group, announced the acquisition of Jan Harrison Limited, trading as Harrison Associates, effective 24 April 2019. Harrison Associates, a nationwide provider of catastrophic injury case management, rehabilitation and expert witness services, will remain an autonomous business unit. The deal is part of handl Group's ongoing acquisition strategy.EclipsecfCase Management, Expert Witness & Rehabilitation: M&A insightsThe UK case management, expert witness, and rehabilitation sector is experiencing significant M&A activity driven by private equity and corporate acquirers seeking consolidation in this fragmented market. Key players such as Handl Group, Frenkel Topping, and HCML are executing multiple deals to expand geographical reach and specialisms, while leveraging technology for efficiency gains. The article anticipates continued deal-making in the short to mid-term due to strong buyer appetite.